Trial intelligence / Profile preview

Levo-bencyclane hydrochloride tablets for prevention of motion sickness

CTR20140259Phase 3Completed

Sponsor
Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences, People's Liberation Army of China
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of levo-bencyclane hydrochloride in motion sickness, sponsored by Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences, People's Liberation Army of China. Started May 2014; status: completed.

02

Drugs

levo-bencyclane hydrochloride
03

Conditions

motion sickness

Beyond the preview

Go deeper on CTR20140259.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140259.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call